Search

Search Funnelback University

Search powered by Funnelback
10 results 20 results 50 results
Relevance Date (Newest first) Date (Oldest first) Title (A-Z) Title (Z-A) Distance URL (A-Z) URL (Z-A) Shuffle
21 - 30 of 3,952 search results for download

  1. Fully-matching results

  2. Early detection of dementia

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=26291
    26 Apr 2024: Early detection of dementia. BACKGROUND. Diagnosis at early stages of neurocognitive decline has major implications for timelyclinical management. We currently intervene too late and often target the wrongpatients. With the recent approval of drugs
    By: Cambridge Enterprise

  3. Wearables for EEG monitoring

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=26297
    26 Apr 2024: Wearables for EEG monitoring. BACKGROUND. Wet EEG electrodes that use an electrolyte gel to form a conductive path betweenthe skin and electrode to reduce the electrode-skin impedance provide a goodquality EEG signal for only a short duration.
    By: Cambridge Enterprise

  4. Sparxell

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=25027
    26 Apr 2024: Sparxell. Sparxell. THE NEXT GENERATION OF COLOURS ANDEFFECTS. Website. The Challenge. Glitters can take many sizes and shapes (from the sequins used in fashion to thefine powder used in the paint of 1 in 4 cars sold in Europe or found in
    By: Cambridge Enterprise

  5. Charged materials for CO2 capture

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=26241
    26 Apr 2024: Charged materials for CO2 capture. BACKGROUND. Current technologies for CO2 capture are based upon organic amines or inorganichydroxides, but neither is ideal. For example, amines are prone to degradationwhen regenerated, and are therefore expensive
    By: Cambridge Enterprise

  6. OSAIRIS: AI cancer imaging tool

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=26293
    26 Apr 2024: OSAIRIS: AI cancer imaging tool. BACKGROUND. Starting radiotherapy promptly improves cancer survival rates and reduces anxietyin newly diagnosed patients. But before any radiotherapy can take place, theoncologist must spend a significant amount of
    By: Cambridge Enterprise

  7. Biophonics

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=25018
    26 Apr 2024: Biophonics. Biophonics. ENABLING WIDESPREAD EARLY DETECTIONOF VALVULAR HEART DISEASE WITH AUNIQUE MEDICAL DEVICE. Website. Overview. Nearly 2 million people in the UK suffer from significant valvular heart disease, yetmore than half remain
    By: Cambridge Enterprise

  8. OutSee

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=25024
    26 Apr 2024: OutSee. OutSee. DISCOVERING NOVEL DRUG TARGETS USINGAN INNOVATIVE AI GENOMICS TECHNOLOGYTHAT UNCOVERS DISEASE-MODULATINGBIOLOGICAL MECHANISMS. Website. Overview. OutSee is being launched to take advantage of the opportunity to exploit large-scale
    By: Cambridge Enterprise

  9. 360° implant to treat spinal cord injuries

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=26299
    26 Apr 2024: 360 implant to treat spinal cord injuries. BACKGROUND. The spinal cord is a key organ of the nervous system, which is in charge of carryinginformation around the body. Every year between 250,000-500,000 people sufferinjuries to the spinal cord
    By: Cambridge Enterprise

  10. MutREAD – Mutational Signature Detection by Restriction…

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=23223
    26 Apr 2024: MutREAD – Mutational Signature Detection byRestriction Enzyme-Associated DNA Sequencing. BACKGROUND. The successful application of mutational signatures in clinical settingsrequires availability of a cost-effective, scalable detection method that
    By: Cambridge Enterprise

  11. PredictImmune

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=24604
    26 Apr 2024: PredictImmune. PredictImmune. HELPING PATIENTS DIAGNOSED WITHCHRONIC IMMUNE-MEDIATED DISORDERS TOLIVE NORMAL AND HEALTHY LIVES. Website. Overview. PredictImmune developes prognostic assays that predict disease progression forpatients with
    By: Cambridge Enterprise

Refine your results

clear all

Format

Date

Related searches for download

By type

By site

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.